FGF21 and type 2 diabetes mellitus: A cohort study in China, encompassing 312 patients with T2DM who had their baseline FGF21 levels measured and were subsequently followed for 6 months, defined renal endpoint events as a 30% decrease in eGFR or worsening categories of albuminuria.